TD Ameritrade Investment Management’s Integra LifeSciences IART Stock Holding History

TD Ameritrade Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-72	Closed	-$4K	–	616
2022 Q2	$4K	Sell	72 -7	-9%	-$420	﹤0.01%	488
2022 Q1	$5K	Buy	79 +7	+10%	+$461	﹤0.01%	549
2021 Q4	$5K	Buy	72 +49	+213%	+$3.31K	﹤0.01%	534
2021 Q3	$1K	Sell	23 -13	-36%	-$918	﹤0.01%	618
2021 Q2	$2K	Buy	36 +16	+80%	+$1.13K	﹤0.01%	595
2021 Q1	$1K	Hold	20	–	–	﹤0.01%	610
2020 Q4	$1K	Sell	20 -3	-13%	-$161	﹤0.01%	610
2020 Q3	$1K	Hold	23	–	–	﹤0.01%	618
2020 Q2	$1K	Sell	23 -3	-12%	-$147	﹤0.01%	610
2020 Q1	$1K	Sell	26 -6	-19%	-$315	﹤0.01%	583
2019 Q4	$2K	Buy	32 +28	+700%	+$1.67K	﹤0.01%	575
2019 Q3	$0	Buy	+4	New	+$238	﹤0.01%	669

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TD Ameritrade Investment Management's IART Position: Q3 2022 in Review

TD Ameritrade Investment Management sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 72 shares — an estimated $4K sold.

TD Ameritrade Investment Management first reported a position in IART in Q3 2019 and held it in 12 quarters. The position peaked at $5K in Q1 2022. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

TD Ameritrade Investment Management reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
TD Ameritrade Investment Management sold 72 Integra LifeSciences shares in Q3 2022, an estimated $4K.
TD Ameritrade Investment Management first reported a position in Integra LifeSciences in Q3 2019 and held it in 12 quarters.
TD Ameritrade Investment Management's Integra LifeSciences position peaked at $5K in Q1 2022.
282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.